PV Bulletin

Early Alert: Convenience Kit Issue from AVID Medical

AVID Medical is correcting convenience kits containing recalled Huons Co. sodium chloride ampules.

Primary source: What is an Early Alert?

PV Impact Brief

Urgency: HighConfidence: high

What changed

AVID Medical must quarantine all impacted convenience kits and has issued recommendations to customers to remove and discard specific sodium chloride ampules before continued use.

Why it matters

This alert highlights a significant safety risk related to specific medical devices and emphasizes the need for compliance with regulatory guidelines to prevent potential harm to patients.

Action needed

Affected users must identify, segregate, and quarantine the kits, add warning labels, and ensure the removal of the recalled components prior to use.

Relevant for
Regulatory Intelligence Lead
Processes impacted
Signal Management
Owner

Regulatory Intelligence Lead

Review cadence

Review in the next regulatory intelligence cycle.

Evidence and confidence

Confidence: highSource updated: Sep 2, 2026

Full briefing

Practical implication

Affected users must identify, segregate, and quarantine the kits, add warning labels, and ensure the removal of the recalled components prior to use.

The FDA has issued an Early Alert regarding potential high-risk issues associated with convenience kits from AVID Medical, which contain recalled sodium chloride ampules from Huons Co. Medical advice includes quarantining affected kits and implementing new labeling.

What changed: AVID Medical must quarantine all impacted convenience kits and has issued recommendations to customers to remove and discard specific sodium chloride ampules before continued use.

Why it matters: This alert highlights a significant safety risk related to specific medical devices and emphasizes the need for compliance with regulatory guidelines to prevent potential harm to patients.

Practical implication: Affected users must identify, segregate, and quarantine the kits, add warning labels, and ensure the removal of the recalled components prior to use.

View original source

  • Source: FDA - MedWatch Safety Alerts RSS
  • Published at source: 2026-09-02T00:00:00.000Z
  • Discovered by monitor: 2026-09-02T21:40:20.833Z

Published from the regulator source ingestion pipeline after PV impact triage.

#Safety Signals#Device Vigilance#Source-ingestion#Regulator-monitor#Usa#Fda.gov

Related updates for your role

publicFDA · USA · Updated Sep 4, 2026

FDA Grants Accelerated Approval to Etcamah for Advanced Breast Cancer

Urgency: High

Regulatory teams must prepare for updating labeling to include details on the new indication and required diagnostic methods, along with planning for the confirmatory studies mandated by the FDA.

Signal ManagementLabelingRegulatory Intelligence Lead
SOP Impact2 SOPs
ConfidenceHigh
Relevant for: Regulatory Intelligence Lead
verifiedRegulatory action: Regulators
Read impact briefarrow_forward
publicMHRA · UK · Updated Sep 4, 2026

Change to the definition of regulated activity with children from 1 September 2026

Urgency: High

Organizations must re-evaluate roles related to children's activities and prepare to request Enhanced DBS checks including access to the Children’s Barred List check starting from 1 September 2026.

Country ComplianceRegulatory Intelligence Lead
SOP Impact1 SOPs
ConfidenceHigh
Relevant for: Regulatory Intelligence Lead
verifiedRegulatory action: Regulators
Read impact briefarrow_forward
publicUK Health Security Agency · UK · Updated Sep 7, 2026

Low Flu Vaccination Rates Among Primary School Children

Urgency: High

Parents are reminded to complete and return flu vaccination consent forms promptly as vaccination sessions in schools are set to start this week, aiming for completion by late November.

Signal ManagementPV Quality Lead
SOP Impact1 SOPs
ConfidenceHigh
Relevant for: PV Quality Lead, Medical Safety Lead
verifiedRegulatory action: Regulators
Read impact briefarrow_forward
publicANSM (France) · France · Updated Sep 7, 2026Translated From French

Recall of Gore Viabahn Endoprosthesis with Bioactive Heparin Coating

Urgency: High

Health establishments receiving affected devices must be notified, and protocols established to ensure compliance with the recall.

Signal ManagementQPPV
SOP Impact1 SOPs
ConfidenceHigh
Relevant for: QPPV, Medical Safety Lead
verifiedRegulatory action: Regulators
Read impact briefarrow_forward